Institut de Recerca contra la Leucèmia Josep Carreras logo

Institut de Recerca contra la Leucèmia Josep Carreras

The Josep Carreras Leukaemia Research Institute was founded in 2010, by the Josep Carreras Foundation and the Government of Catalonia, as the first European research centre devoted exclusively to leukaemia and other malignant blood diseases, and one of the few that exist in the world. We investigat...

201-500 employees

The Josep Carreras Leukaemia Research Institute was founded in 2010, by the Josep Carreras Foundation and the Government of Catalonia, as the first European research centre devoted exclusively to leukaemia and other malignant blood diseases, and one of the few that exist in the world.

We investigate basic, epidemiological, preventive, clinical, and translational aspects of leukaemia and other hematologic malignancies.

Our research aims to identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and development of leukaemias and other malignant haematological pathologies, to be able to prevent them.

We work for a future in which all leukaemias will be curable. Our fight will endure until there's a cure.

Frequently Asked Questions

How many employees does Institut de Recerca contra la Leucèmia Josep Carreras have?

Institut de Recerca contra la Leucèmia Josep Carreras has around 351 employees. As a Research Services company, they are actively growing their team with 0 open positions.

Why should I join Institut de Recerca contra la Leucèmia Josep Carreras?

Institut de Recerca contra la Leucèmia Josep Carreras is a leading Research Services company offering exciting career opportunities. With 0 open positions, now is a great time to join their growing team.

What does Institut de Recerca contra la Leucèmia Josep Carreras do?

Institut de Recerca contra la Leucèmia Josep Carreras is a Research Services company. The Josep Carreras Leukaemia Research Institute was founded in 2010, by the Josep Carreras Foundation and the Government of Catalonia, as the first European research centre devoted exclusively to leuk...